Stock overview
Apogee Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
Historical Apogee Therapeutics common stock, traded as APGE. AbbVie acquired the company for $135.11 cash per share before trading opened on September 3, 2026. Nasdaq identifies September 2 as the last trading date.
- Last close
- $135.07
- · APGE
- Tracked holders
- 0 funds
- Latest available 13F per fund
APGE · USD
Price
Close · Sep 2, 2026
- Range low
- $135.07
- Range high
- $135.07
- Observations
- 1
- Session date
- Sep 2, 2026
Sep 2, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Latest reported institutional positions from SEC 13F filings.
No tracked fund's latest available 13F reports APGE.
This state describes the stored filings; it does not imply a current position.
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market